Skip to main content
Premium Trial:

Request an Annual Quote

Precision BioSciences Raises $25.6M in Series A Financing

NEW YORK (GenomeWeb) – Precision BioSciences today announced it has closed a $25.6 million Series A financing round.

Life sciences investor VenBio led the round, joined by Fidelity Biosciences, Amgen Ventures, Baxter Ventures, Osage University Partners, the Longevity Fund, and two unnamed public market investors.

"This financing will allow us to expand beyond our successful efforts to develop the leading next-gen genome editing platform and significantly accelerate the development of our genome-edited product pipeline," Precision BioSciences CEO Matthew Kane said in a statement.

Precision BioSciences' Arcus genome editing platform can remove, insert, and modify DNA at any location in the genome, the firm said in a statement, combining the target site flexibility of CRISPR/Cas9 along with the site specificity of homing endonucleases.

The Research Triangle Park, North Carolina-based company has signed collaborations to use its genome engineering platform in castor plants and corn.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.